Experts recently uncovered evidence suggesting behaviors such as undereating, binging and purging could be owed to anatomical alterations in parts of the brain.
Results from the world’s largest prospective artificial intelligence study revealed the system could significantly benefit breast cancer screening programs.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
That’s according to new PET imaging that shows the presence of activated T cells in the brain, spinal cord, gut and lung tissues of individuals who have recovered from COVID.
Between the ages of 8 and 12, MRI scans of children with ADHD show significantly lower cerebral blood flow in regions of the brain known to be related to attention, motor skills, executive function and impulsivity.
The grant will fund a team at the UCLA Health Jonsson Comprehensive Cancer Center working to identify genetic biomarkers capable of predicting RT side effects.
A paper in the Journal of Vascular and Interventional Radiology offers new guidance on how ablation volumes affect renal function in solitary kidneys and highlights ranges that pose the least risk to patients.
The more an individual’s score changes, the greater the odds are of them being diagnosed with cancer in the near future, new research presented at SIIM 2024 suggests.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
